{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:28:13Z","timestamp":1787120893601,"version":"build-2736575974"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure following acute myocardial infarction (AMI) is a prevalent and severe cardiovascular complication, which markedly elevates the risks of mortality and readmission in affected patients. Although reperfusion therapy and standardized Western medical pharmacotherapy can ameliorate clinical prognosis, a subset of patients still progress to heart failure due to ventricular remodeling and sustained neuroendocrine activation. In recent years, traditional Chinese medicine injections (TCMIs) combined with conventional western medicine (CWM) have exhibited potential merits in enhancing cardiac function, suppressing inflammatory response and delaying ventricular remodeling. Nevertheless, systematic comparisons regarding the relative efficacy and safety of various combination regimens remain insufficient. Accordingly, it is essential to systematically assess the efficacy and safety of different TCMIs plus conventional therapy for heart failure post AMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic retrievals were performed across seven databases: China National Knowledge Infrastructure, VIP Database, Wanfang Data, Chinese Biomedical Literature Database, PubMed, Web of Science and Cochrane Library, with the retrieval period spanning from January 1, 2016 to June 1, 2026. Randomized controlled trials (RCTs) investigating TCMIs combined with conventional Western regimens for heart failure after acute myocardial infarction were enrolled. Stata and R statistical software were utilized to conduct network meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 62 eligible RCTs containing 5922 participants and covering 8 varieties of TCMIs were ultimately included. Network meta-analysis (NMA) demonstrated that all eight TCMIs combination regimens could significantly raise clinical response rate, modulate indicators reflecting cardiac function and myocardial injury, decrease the concentrations of inflammatory factors, accompanied by low incidence rates of major adverse cardiovascular events (MACE) and adverse reactions. The results of the surface under the cumulative ranking curve (SUCRA) indicated that Shenfu Injection plus conventional Western therapy achieved the optimal efficacy in elevating cardiac output and stroke volume, as well as reducing N-terminal pro-B-type natriuretic peptide and tumor necrosis factor-\u03b1. Xinmailong Injection ranked favorably in lowering interleukin-6 and endothelin-1. Shenmai Injection obtained the highest SUCRA rankings in boosting left ventricular ejection fraction, ameliorating left ventricular end-systolic diameter, heart rate and B-type natriuretic peptide. Yiqi Fumai Injection presented superior rankings in improving cardiac index, diastolic blood pressure, creatine kinase isoenzyme-MB and reducing the occurrence of MACE. Xuebijing Injection occupied the top SUCRA position in improving overall clinical efficacy and decreasing cardiac troponin I and high-sensitivity C-reactive protein. Shuxuening Injection ranked first in adjusting left ventricular end-diastolic diameter and systolic blood pressure, while Huangqi Injection yielded the best outcomes in improving left ventricular end-systolic volume and Left Ventricular End-Diastolic Volume. All above findings were derived from indirect comparative evidence, requiring further verification via subsequent head-to-head direct comparative trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Restricted by low-certainty evidence, all eight TCMIs combined with CWM can preliminarily improve clinical efficacy, optimize parameters of cardiac function and myocardial injury, and inhibit inflammatory levels in patients with heart failure post AMI, with mild MACE and adverse events. However, the evidence network in this analysis is predominantly star-shaped without closed loops, lacking direct head-to-head comparisons among distinct TCMIs. Additionally, the included trials are limited by small sample sizes, methodological flaws and substantial clinical heterogeneity. Therefore, the current outcomes merely serve as exploratory hypotheses rather than definitive clinical conclusions. Large-sample, multicenter and high-quality RCTs are still warranted to validate these preliminary findings and generate evidence-based references for individualized precise clinical medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261428750<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1921437","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:48:22Z","timestamp":1787118502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of traditional Chinese medicine injections combined with conventional Western medicine for post-AMI heart failure: a systematic review and Bayesian network meta-analysis of 62 randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhan-Ze","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Chai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, the Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital of Traditional Chinese Medicine , Zhongshan","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Yao","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Zhu","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Xue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine \u2161, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7619\/jcmp.20255184","article-title":"Mechanism innovation and therapeutic advances in heart failure after acute myocardial infarction","volume":"30","author":"Ren","year":"2026","journal-title":"J Clin Med Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"oeaf013","DOI":"10.1093\/ehjopen\/oeaf013","article-title":"15-Year Trends, predictors, and outcomes of heart failure hospitalization complicating first acute myocardial infarction in the modern percutaneous coronary intervention era","volume":"5","author":"Rashid","year":"2025","journal-title":"Eur Heart J Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1253\/circj.CJ-24-0633","article-title":"Pharmacological and device-based intervention for preventing heart failure after acute myocardial infarction- A clinical review","volume":"88","author":"Saito","year":"2024","journal-title":"Circ J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2024.12.004","article-title":"Patterns and prognostic impact of postdischarge ischemic, bleeding, and heart failure events after myocardial infarction","volume":"239","author":"Okita","year":"2025","journal-title":"Am J Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/eurheartj\/ehae885","article-title":"Incident heart failure and recurrent coronary events following acute myocardial infarction","volume":"46","author":"Butler","year":"2025","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"927163","DOI":"10.3389\/fphys.2022.927163","article-title":"Role of inflammation in cardiac remodeling after acute myocardial infarction","volume":"13","author":"Fonseca","year":"2022","journal-title":"Front Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1253\/circrep.CR-24-0141","article-title":"Clinical review of cardiogenic shock after acute myocardial infarction- revascularization, mechanical circulatory support, and beyond","volume":"7","author":"Saito","year":"2024","journal-title":"Circ Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tcm.2024.10.002","article-title":"Guidelines for treating heart failure","volume":"35","author":"Kittleson","year":"2025","journal-title":"Trends Cardiovasc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2024.02.020","article-title":"Contemporary American and European guidelines for heart failure management: jACC: heart failure guideline comparison","volume":"12","author":"Ostrominski","year":"2024","journal-title":"JACC Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/AGINGADV.AGINGADV-D-24-00025","article-title":"Artificial intelligence in age-related cardiogenic shock prediction: a systematic review and meta-analysis","volume":"2","author":"Popat","year":"2025","journal-title":"Aging Adv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4103\/mgr.MEDGASRES-D-24-00107","article-title":"Application and progress of hyperbaric oxygen therapy in cardiovascular diseases","volume":"15","author":"Tian","year":"2025","journal-title":"Med Gas Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/mgr.MEDGASRES-D-23-00007","article-title":"Insights into the use of oxygen-ozone therapy in ischemic cardiopathy and cardiovascular disease: a role for mitochondria?","volume":"14","author":"Pandolfi","year":"2024","journal-title":"Med Gas Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1511486","DOI":"10.3389\/fphar.2025.1511486","article-title":"Traditional Chinese medicine injections with tonifying qi, equivalent effect of regulating energy metabolism, for acute myocardial infarction: a systematic review and meta-analysis of randomized clinical trials","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"659707","DOI":"10.3389\/fphar.2021.659707","article-title":"Efficacy and safety of traditional Chinese medicine injections for heart failure with reduced ejection fraction: a Bayesian network meta-analysis of randomized controlled trials","volume":"12","author":"Lin","year":"2021","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.19540\/j.cnki.cjcmm.20230724.501","article-title":"Chinese Medicine injections in treating post-acutemyocardial infarction heart failure network meta-analysis of efficacy and safety of different traditional","volume":"48","author":"Sun","year":"2023","journal-title":"China J Chin Mater Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.19296\/j.cnki.1008-2409.2019-01-015","article-title":"Effects of shenfu injection on hemorheology and neuroendocrine hormones in the treatment of acute myocardial infarction with acute heart failure","volume":"32","author":"You","year":"2019","journal-title":"Acta Med Sinica"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3969\/j.issn.1006-2084.2016.15.057","article-title":"Analysis of shenfu injection improvement of cardiac function and curative effect for patients of acute myocardial infarction with heart failure","volume":"22","author":"Li","year":"2016","journal-title":"Med Recapitulate"},{"key":"B18","first-page":"127","article-title":"Efficacy of shenfu injection in adjuvant treatment of acute myocardial infarction complicated with heart failure","volume":"40","author":"Wang","year":"2021","journal-title":"Inner Mong J Tradit Chin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.19347\/j.cnki.2096-1413.201829063","article-title":"Effect of shenfu injection combined with PCI on improvement of cardiac function and prognosis in patients with acute myocardial infarction complicated with cardiac dysfunction","volume":"3","author":"Zhang","year":"2018","journal-title":"Curr Med Res Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3969\/j.issn.2095-4441.2017.02.003","article-title":"Clinical observation of continuous intravenous infusion of shenfu injection combined with dopamine for pump failure after PCI in patients with acute myocardial infarction","volume":"20","author":"Wang","year":"2017","journal-title":"J Guangxi Univ Chin Med"},{"key":"B21","first-page":"14","article-title":"Clinical observation of continuous intravenous infusion of shenfu injection combined with dopamine for pump failure after PCI in patients with acute myocardial infarction. China association of Chinese medicine; guangdong provincial association of Chinese medicine; cross-strait medical and health association","volume-title":"Proceedings of the 13th Southern Symposium on Cardiovascular Diseases of Traditional Chinese Medicine","author":"Wu","year":"2017"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.7501\/j.issn.1674-6376.2019.10.028","article-title":"Effect analysis on shenfu injection combined with enoxaparin sodium in treatment of acute myocardial infarction complicated with heart failure","volume":"42","author":"Feng","year":"2019","journal-title":"Drug Eval Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3969\/j.issn.1004-745X.2024.04.030","article-title":"Intervention effect of shenfu injection combined with pulmonary ultrasound on acute Inferior right ventricular myocardial infarction","volume":"33","author":"Tan","year":"2024","journal-title":"JETCM"},{"key":"B24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.15975\/j.cnki.gsyy.2019.10.021","article-title":"Clinical efficacy of shenfu injection for acute myocardial infarction complicated with heart failure","volume":"38","author":"Ma","year":"2019","journal-title":"Gansu Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.16448\/j.cjtcm.2017.0622","article-title":"Clinical study of shenfu injection in the treatment of acute myocardial infarction with pump failure","volume":"29","author":"Li","year":"2017","journal-title":"Clin J Tradit Chin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3969\/j.issn.1004-745X.2019.02.037","article-title":"Clinical observation of shenfu injection in the treatment of acute myocardial infarction complicated with heart failure","volume":"28","author":"Zhang","year":"2019","journal-title":"JETCM"},{"key":"B27","first-page":"19","article-title":"Efficacy analysis of shenfu injection combined with dobutamine in patients with acute myocardial infarction complicated with heart failure","volume":"1","author":"Yang","year":"2019","journal-title":"Health Req Read"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3969\/j.issn.1008-8849.2016.13.016","article-title":"Effects of recombinant human brain natriuretic peptide combined with shenfu injection on cardiac function and neuroendocrine hormone levels in patients with acute myocardial infarction complicated with pump failure","volume":"25","author":"Zhao","year":"2016","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3969\/j.issn.1002-7386.2018.01.004","article-title":"Effects of recombinant human brain natriuretic peptide combined with shenfu injection on cardiac function and neuroendocrine hormone levels of patients with acute myocardial infarction complicated by pump failure","volume":"40","author":"Zhang","year":"2018","journal-title":"Hebei Med J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.13898\/j.cnki.issn.1000-2200.2018.01.018","article-title":"Effect of recombinant human brain natriuretic peptide combined with shenfu injection in the treatment of acute myocardial infarction complicated with acute heart failure","volume":"43","author":"Wang","year":"2018","journal-title":"J Bengbu Med Coll"},{"key":"B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3969\/j.issn.1009-4393.2016.15.097","article-title":"Clinical efficacy evaluation of recombinant human brain natriuretic peptide combined with shenfu injection for acute myocardial infarction complicated with acute heart failure","volume":"22","author":"Sun","year":"2016","journal-title":"Contemp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.13935\/j.cnki.sjzx.180130","article-title":"Short-term therapeutic effects and safety on the combined treatment for acute myocardial infarction and heart failure with recombinant human brain natriuretic peptide and shenfu injection","volume":"13","author":"Wang","year":"2018","journal-title":"World J Integr Tradit West Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3969\/j.issn.1672-3015(x).2023.05.001","article-title":"Efficacy analysis of recombinant human brain natriuretic peptide combined with shenfu injection for acute myocardial infarction complicated with heart failure","volume":"13","author":"Zhou","year":"2023","journal-title":"Knowl Prev Treat Cardiovasc Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.3760\/cma.j.issn.1007-1245.2019.21.016","article-title":"Effects of recombinant human brain natriuretic peptide combined with shenfu injection on myocardial remodeling and connexin 43 expression in patients with acute myocardial infarction complicated with heart failure","volume":"21","author":"Wang","year":"2019","journal-title":"IMHGN"},{"key":"B35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/JCM-150517","article-title":"Effects of Xinmailong injection on heart failure after interventional therapy for acute myocardial infarction","volume":"15","author":"Li","year":"2017","journal-title":"JCM"},{"key":"B36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3969\/j.issn.2096-3718.2023.06.030","article-title":"Effects of Xinmailong injection on inflammatory factor levels in patients with heart failure after acute myocardial infarction","volume":"7","author":"Wei","year":"2023","journal-title":"Mod Med Health Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3969\/j.issn.1008-0074.2019.04.21","article-title":"Therapeutic effect of Xinmailong injection on advanced aged patients with acute myocardial infarctionheart failure","volume":"28","author":"Yan","year":"2019","journal-title":"Chin T Cardiocasc Rehabil Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3969\/j.issn.1008-8849.2020.13.003","article-title":"Effect of Xinmailong injection on soluble growth stimulating gene 2 protein expression in patients with heart failure after PCI for acute coronary syndrome","volume":"29","author":"Liu","year":"2020","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12037\/YXQY.2019.03-12","article-title":"Effect of Xinmailong injection on cardiac function and prognosis in patients with acute myocardial infarction complicated with heart failure","volume":"11","author":"Liu","year":"2019","journal-title":"Chin J Med Front (Electron Ed)"},{"key":"B40","first-page":"40","article-title":"Effects of Xinmailong injection on inflammatory factors in patients with heart failure after acute myocardial infarction","volume":"50","author":"Yuan","year":"2019","journal-title":"Jiangxi J Tradit Chin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.12102\/j.issn.1672-1349.2020.23.021","article-title":"Effects of Xinmailong injection on routine blood test and lung ultrasound B-line score in patients with heart failure after emergency PCI for acute myocardial infarction","volume":"18","author":"Xu","year":"2020","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3969\/j.issn.1672-1349.2016.24.018","article-title":"Effects of Xinmailong injection on cardiac function, inflammatory factor levels and miR-23a in elderly patients with heart failure after acute myocardial infarction","volume":"14","author":"Li","year":"2016","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.16306\/j.1008-861x.2022.02.004","article-title":"Effect of Xinmailong injection on heart function and levels of inflammatory factors and miR-23a in elderly patients with heart failure after acute myocardial infarction","volume":"36","author":"Song","year":"2022","journal-title":"Acad J Shanghai Univ Tradit Chin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3969\/j.issn.1004-437X.2024.05.028","article-title":"Clinical effect of Xinmerong injection combined with bisoprolol fumarate tablet in the treatment of patients with heart failure caused by acute myocardial infarction","volume":"33","author":"Wang","year":"2024","journal-title":"Henan Med Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.11966\/j.issn.2095-994X.2019.05.07.04","article-title":"Efficacy and inflammatory factors analysis of Xinmailong injection combined with levosimendan in elderly patients with heart failure after acute myocardial infarction","volume":"5","author":"Wang","year":"2019","journal-title":"World J Compos Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3969\/j.issn.1672-1349.2016.01.018","article-title":"Clinical observation on efficacy of Xinmailong injection for heart failure in advanced elderly patients after acute myocardial infarction","volume":"14","author":"Zhang","year":"2016","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3969\/j.issn.1672-1349.2016.01.036","article-title":"Fifty cases of heart failure in elderly patients after acute myocardial infarction treated with Xinmailong injection","volume":"14","author":"Li","year":"2016","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3969\/j.issn.1671-3141.2016.100.106","article-title":"Efficacy of shenmai injection combined with dobutamine for acute myocardial infarction complicated with heart failure","volume":"16","author":"Xu","year":"2016","journal-title":"World Latest Medicine Information"},{"key":"B49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3969\/j.issn.1009-816x.2025.01.015","article-title":"Effects of shenmai injection combined with creatine phosphate sodium on cardiac function and hemodynamic parameters in patients with acute myocardial infarction complicated with heart failure","volume":"25","author":"Zhang","year":"2025","journal-title":"Cardio-Cerebrovasc Dis Prev Treat"},{"key":"B50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3969\/j.issn.1006-5180.2021.11.012","article-title":"Effects of shenmai injection combined with revascularization on cardiac function in patients with acute myocardial infarction complicated with heart failure","volume":"28","author":"Lv","year":"2021","journal-title":"Mod Diagn Treat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3969\/j.issn.1001-8174.2017.18.008","article-title":"Effect of shenmai injection combined with revascularization on cardiac function in patients with acute myocardial infarction complicated with heart failure","volume":"28","author":"Yang","year":"2017","journal-title":"Mod Diagn Treat"},{"key":"B52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14164\/j.cnki.cn11-5581\/r.2016.08.132","article-title":"Analysis of clinical efficacy of shenmai injection in patients with heart failure after acute myocardial infarction","volume":"10","author":"Zheng","year":"2016","journal-title":"Chin J Mod Drug Appl"},{"key":"B53","first-page":"88","article-title":"Long-term clinical efficacy of shenmai injection in patients with heart failure after acute myocardial infarction","volume":"27","author":"Cui","year":"2017","journal-title":"China Health Care Nutr"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.16367\/j.issn.1003-5028.2016.10.0700","article-title":"One hundred and five cases of heart failure related to acute myocardial infarction treated with shenmai injection","volume":"36","author":"Zhao","year":"2016","journal-title":"Henan Tradit Chin Med"},{"key":"B55","first-page":"67","article-title":"Clinical efficacy and safety analysis of milrinone combined with shenmai injection for heart failure after acute myocardial infarction","volume":"64","author":"Li","year":"2019","journal-title":"Health Must Read Mag"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.19381\/j.issn.1001-7585.2024.15.012","article-title":"Therapeutic analysis of yiqi fumai lyophilized injection combined with rhBNP for heart failure after acute myocardial infarction","volume":"37","author":"Qiu","year":"2024","journal-title":"J Med Theor & Prac"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3969\/j.issn.1004-745X.2016.06.057","article-title":"Clinical observation of yiqi fumai lyophilized injection combined with rhBNP in patients with acute myocardial infarction complicated with acute heart failure","volume":"25","author":"Zhang","year":"2016","journal-title":"J Emerg Tradit Chin Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.7501\/j.issn.1674-6376.2021.11.033","article-title":"Therapeutic effect of yiqi fumai lyophilized injection combined with milrinone on acute myocardial infarction complicated with heart failure and its effect on serum IL-6 and CRP levels","volume":"44","author":"Li","year":"2021","journal-title":"Drug Eval Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.12332\/j.issn.2095-6525.2024.03.084","article-title":"Clinical efficacy of yiqi fumai lyophilized injection combined with recombinant human brain natriuretic peptide for acute myocardial infarction complicated with heart failure","volume":"3","author":"Qiu","year":"2024","journal-title":"Kang Yi"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.13638\/j.issn.1671-4040.2023.14.004","article-title":"Application efficacy of yiqi fumai lyophilized injection in patients with acute myocardial infarction complicated with heart failure","volume":"23","author":"Gong","year":"2023","journal-title":"Clin J Integr Tradit Chin West Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3969\/j.issn.1002-2619.2016.02.032","article-title":"Observation of yiqi-fumai for injection on the treatment of acute myocardial infarction complicated with left ventricular failure","volume":"38","author":"Li","year":"2016","journal-title":"Hebei J TCM"},{"key":"B62","first-page":"27","article-title":"Clinical efficacy of yiqi fumai lyophilized injection for acute myocardial infarction complicated with heart failure of qi-yin deficiency syndrome","volume":"28","author":"Chen","year":"2018","journal-title":"J Shanxi Med Staff Coll"},{"key":"B63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3969\/j.issn.1674-4659.2024.02.0193","article-title":"Effect of Xuebijing combined with sacubitril valsartan sodium tablet in the treatment of heart failure after acute myocardial infarction","volume":"31","author":"Yao","year":"2024","journal-title":"Clin Med Eng"},{"key":"B64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.13192\/j.issn.1000-1719.2023.02.036","article-title":"Clinical study of Xuebijing injection in adjuvant treatment of acute myocardial infarction with heart failure","volume":"50","author":"Li","year":"2023","journal-title":"Liaoning J Tradit Chin Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3969\/j.issn.1674-4659.2024.03.0283","article-title":"Clinical effect of Xuebijing injection combined with sacubitril valsartan sodium tablets in the treatment of patients with heart failure after acute myocardial infarction","volume":"31","author":"Lu","year":"2024","journal-title":"Clin Med Eng"},{"key":"B66","first-page":"079","article-title":"Clinical efficacy of Xuebijing injection combined with sacubitril\/valsartan sodium tablets in patients with heart failure after acute myocardial infarction","volume":"11","author":"Wang","year":"2024","journal-title":"Chin Sci Technol J Database (Full Text Ed) Med Health"},{"key":"B67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3969\/j.issn.1009-816x.2025.05.007","article-title":"Therapeutic effect of Xuebijing injection combined with levosimendan on acute myocardial infarction complicated by heart failure","volume":"25","author":"Zhang","year":"2025","journal-title":"Cardio-Cerebrovasc Dis Prev Treat"},{"key":"B68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.12385\/j.issn.2096-1278(2025)02-0104-04","article-title":"Efficacy and safety of Xuebijing injection in the treatment of acute ST-elevation myocardial infarction with heart failure","volume":"33","author":"Li","year":"2025","journal-title":"Clin Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.12102\/j.issn.1672-1349.2019.22.026","article-title":"Clinical study of shengmai injection combined with lyophilized recombinant human brain natriuretic peptide for acute myocardial infarction complicated with heart failure","volume":"17","author":"Wang","year":"2019","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"504","DOI":"10.16047\/j.cnki.cn14-1300\/r.2022.07.018","article-title":"Efficacy analysis of shengmai injection combined with dobutamine injection for heart failure after acute myocardial infarction","volume":"31","author":"Lu","year":"2022","journal-title":"Proc Clin Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3969\/j.issn.1007-614x.2016.2.68","article-title":"Curative effect observation of shengmai injection combined with levosimendan in the treatment of acute myocardial infarction associated with pump failure","volume":"32","author":"Yang","year":"2016","journal-title":"Chin Community Dr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3760\/cma.j.issn.1008-6706.2022.01.006","article-title":"Levosimendan combined with shengmai injection for the treatment of pump failure in 55 patients with acute myocardial infarction","volume":"29","author":"Luan","year":"2022","journal-title":"Chin J Prim Med Pharm"},{"key":"B73","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3969\/j.issn.1004-0412.2022.02.059","article-title":"Efficacy of isosorbide mononitrate injection combined with shuxuening injection in patients with acute myocardial infarction complicated with acute left heart failure","volume":"43","author":"Wang","year":"2022","journal-title":"Jilin Med J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3969\/j.issn.1000-744X.2021.11.015","article-title":"Efficacy of isosorbide mononitrate injection combined with shuxuening injection in patients with acute myocardial infarction complicated with acute left heart Failure","volume":"45","author":"Liu","year":"2021","journal-title":"Guizhou Med J"},{"key":"B75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3969\/j.issn.1671-4695.2019.01.009","article-title":"Study on the efficacy of isosorbide mononitrate injection combined with shuxuening injection in treatment of patients with acute myocar dial infarction associated with acute left heart failure","volume":"18","author":"Qin","year":"2019","journal-title":"J Clin Exp Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3969\/j.issn.1008-0074.2019.04.09","article-title":"Influence of recombinant human BNP combined Astragalus injection on heart function and serum levels of inflammatory factors in AMI patients with post- PCI heart failure","volume":"28","author":"Xian","year":"2019","journal-title":"Chin J Cardiovasc Rehabil Me"},{"key":"B77","article-title":"Effects of recombinant human brain natriuretic peptide (rhBNP) combined with Astragalus injection on cardiac function and Serum inflammatory factor levels in patients with heart failure after PCI for acute myocardial infarction (AMI)","volume":"17","author":"Fu","year":"2021","journal-title":"Women\u2019s Health"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.7507\/1672-2531.202002172","article-title":"Rating the certainty of evidence from network meta-analysis: an introduction to CINeMA","volume":"20","author":"Wang","year":"2020","journal-title":"Chin J Evid Based Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.cpcardiol.2022.101215","article-title":"Heart failure after ST-elevation myocardial infarction: beyond left ventricular adverse remodeling","volume":"48","author":"Del Buono","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","article-title":"Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction","volume":"21","author":"Galli","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamacardio.2022.2847","article-title":"Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction: a review","volume":"7","author":"Harrington","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1533105","DOI":"10.3389\/fcvm.2025.1533105","article-title":"Regenerative therapies for myocardial infarction: exploring the critical role of energy metabolism in achieving cardiac repair","volume":"12","author":"Ren","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3760\/cma.j.issn.1671-0282.2024.03.015","article-title":"An exploratory randomized controlled study on early application of shenfu injection to prevent septic cardiomyopathy","volume":"33","author":"Sun","year":"2024","journal-title":"Chin J Emerg Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.12114\/j.issn.1007-9572.2025.0297","article-title":"Expert consensus on the use of traditional Chinese patent medicines in the prevention and treatment of pan-vascular diseases and their target organ damage","volume":"29","author":"Tao","year":"2026","journal-title":"Chin Gen Pract"},{"key":"B89","doi-asserted-by":"publisher","first-page":"943","DOI":"10.16025\/j.1674-1307.2023.09.003","article-title":"Effect of shenmai injection on myocardial injury and hemodynamics in post-cardiac arrest syndrome","volume":"42","author":"Li","year":"2023","journal-title":"Beijing J Tradit Chin Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.13422\/j.cnki.syfjx.20220790","article-title":"Cardiovascular protective effect of shenmai injection: a review","volume":"29","author":"Huang","year":"2023","journal-title":"Chin J Exp Tradit Med Formulae"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1921437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:49:10Z","timestamp":1787118550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1921437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":90,"alternative-id":["10.3389\/fcvm.2026.1921437"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1921437","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1921437"}}